Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: a first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trial
作者
Kirsten E. Lyke,Andrea A. Berry,Matthew B. Laurens,Jennifer L. Winkler,Sudhaunshu Joshi,Abra Rachida Koudjra,Lauryn Butler,Peter F. Billingsley,Tales Vicari Pascini,Asha Patil,B. Kim Lee Sim,Grace Fitzgerald,Julie Riegel,Kayla Andrews,Micha Levi,Aparna B Anderson,Charles D. Wells,Hong Liu,James W. Huleatt,R Scott Miller